BR9710179A - Preparação hidrofóbica preparação em emulação farmacéutica e uso de uma preparação hidrofóbica - Google Patents
Preparação hidrofóbica preparação em emulação farmacéutica e uso de uma preparação hidrofóbicaInfo
- Publication number
- BR9710179A BR9710179A BR9710179A BR9710179A BR9710179A BR 9710179 A BR9710179 A BR 9710179A BR 9710179 A BR9710179 A BR 9710179A BR 9710179 A BR9710179 A BR 9710179A BR 9710179 A BR9710179 A BR 9710179A
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- hydrophobic
- emulation
- pharmaceutical
- hydrophobic preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9613858.1A GB9613858D0 (en) | 1996-07-02 | 1996-07-02 | Hydrophobic preparations |
PCT/GB1997/001775 WO1998000169A1 (en) | 1996-07-02 | 1997-07-02 | Hydrophobic preparations containing medium chain monoglycerides |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9710179A true BR9710179A (pt) | 1999-08-10 |
Family
ID=10796214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9710179A BR9710179A (pt) | 1996-07-02 | 1997-07-02 | Preparação hidrofóbica preparação em emulação farmacéutica e uso de uma preparação hidrofóbica |
Country Status (13)
Country | Link |
---|---|
US (1) | US6258377B1 (pt) |
EP (1) | EP0910411A1 (pt) |
JP (1) | JP2000515130A (pt) |
KR (1) | KR20000022353A (pt) |
AU (1) | AU709013B2 (pt) |
BR (1) | BR9710179A (pt) |
CA (1) | CA2259233A1 (pt) |
GB (1) | GB9613858D0 (pt) |
ID (1) | ID18568A (pt) |
NO (1) | NO986211L (pt) |
NZ (1) | NZ333115A (pt) |
WO (1) | WO1998000169A1 (pt) |
ZA (1) | ZA975856B (pt) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2294988C (en) | 1997-07-01 | 2015-11-24 | Isis Pharmaceuticals Inc. | Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
AU745880B2 (en) | 1998-05-21 | 2002-04-11 | Isis Pharmaceuticals, Inc. | Compositions and methods for non-parenteral delivery of oligonucleotides |
US6242001B1 (en) * | 1998-11-30 | 2001-06-05 | Mcneil-Ppc, Inc. | Method for producing dispersible sterol and stanol compounds |
WO2000033866A1 (en) * | 1998-12-04 | 2000-06-15 | Provalis Uk Limited | Pharmaceutical compositions containing insulin |
US8895064B2 (en) | 1999-06-14 | 2014-11-25 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
PT1183014E (pt) | 1999-06-14 | 2003-12-31 | Cosmo Spa | Composicoes farmaceuticas orais de libertacao controlada e de dissimulacao de sabor |
US7169889B1 (en) * | 1999-06-19 | 2007-01-30 | Biocon Limited | Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin |
GB2355009A (en) | 1999-07-30 | 2001-04-11 | Univ Glasgow | Peptides conjugated to bile acids/salts |
AU778851B2 (en) * | 1999-10-08 | 2004-12-23 | Coty Bv | Cosmetic preparation of active substances with a synergistically increased radical protection factor |
WO2002051428A1 (fr) * | 2000-12-25 | 2002-07-04 | Shiseido Company, Ltd. | Composition de parfum stimulant le systeme sympathique |
KR100508695B1 (ko) * | 2001-02-13 | 2005-08-17 | 한국과학기술연구원 | 인슐린의 경구투여용 제형과 그의 제조방법 |
US7060675B2 (en) * | 2001-02-15 | 2006-06-13 | Nobex Corporation | Methods of treating diabetes mellitus |
CN1160122C (zh) | 2001-04-20 | 2004-08-04 | 清华大学 | 一种制备口服胰岛素油相制剂的方法 |
US20030143191A1 (en) * | 2001-05-25 | 2003-07-31 | Adam Bell | Chemokine beta-1 fusion proteins |
US6713452B2 (en) | 2001-06-04 | 2004-03-30 | Nobex Corporation | Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
US7713932B2 (en) | 2001-06-04 | 2010-05-11 | Biocon Limited | Calcitonin drug-oligomer conjugates, and uses thereof |
US6835802B2 (en) | 2001-06-04 | 2004-12-28 | Nobex Corporation | Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties |
US6828297B2 (en) | 2001-06-04 | 2004-12-07 | Nobex Corporation | Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
US6828305B2 (en) * | 2001-06-04 | 2004-12-07 | Nobex Corporation | Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
US6913903B2 (en) * | 2001-09-07 | 2005-07-05 | Nobex Corporation | Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
US7166571B2 (en) * | 2001-09-07 | 2007-01-23 | Biocon Limited | Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
US6770625B2 (en) | 2001-09-07 | 2004-08-03 | Nobex Corporation | Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith |
US7312192B2 (en) * | 2001-09-07 | 2007-12-25 | Biocon Limited | Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
US7030082B2 (en) * | 2001-09-07 | 2006-04-18 | Nobex Corporation | Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith |
CA2471363C (en) | 2001-12-21 | 2014-02-11 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
GB0308734D0 (en) | 2003-04-15 | 2003-05-21 | Axcess Ltd | Uptake of macromolecules |
GB0308732D0 (en) * | 2003-04-15 | 2003-05-21 | Axcess Ltd | Absorption enhancers |
PL1729797T3 (pl) | 2004-03-22 | 2009-02-27 | Abbott Laboratories Gmbh | Doustne kompozycje farmaceutyczne produktów zawierających lipazę, a zwłaszcza pankreatynę, zawierające środki powierzchniowo czynne |
CA2580313C (en) | 2004-07-19 | 2016-03-15 | Biocon Limited | Insulin-oligomer conjugates, formulations and uses thereof |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
CN101233229B (zh) | 2005-07-29 | 2013-05-01 | 雅培实验室有限公司 | 制备消毒的胰酶粉末的方法 |
US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
US11266607B2 (en) | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
US10072256B2 (en) | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
JP5143131B2 (ja) | 2006-05-30 | 2013-02-13 | インターシア セラピューティクス,インコーポレイティド | 浸透圧送出システムの二片構成内部チャネル型の流れモジュレータ |
US8940719B2 (en) * | 2006-07-03 | 2015-01-27 | Academia Sinica | Lithocholic acid analogues that inhibit sialyltransferase |
PL2359808T3 (pl) | 2006-08-09 | 2013-10-31 | Intarcia Therapeutics Inc | Osmotyczne systemy dostawcze i zespoły tłokowe |
CA2683610C (en) | 2007-04-23 | 2013-01-08 | Intarcia Therapeutics, Inc. | Suspension formulations of insulinotropic peptides and uses thereof |
JP5868594B2 (ja) | 2007-10-16 | 2016-02-24 | バイオコン・リミテッドBiocon Limited | 経口投与可能な固形医薬組成物及びそのプロセス |
DK2240155T3 (da) | 2008-02-13 | 2012-09-17 | Intarcia Therapeutics Inc | Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler |
WO2009149418A2 (en) * | 2008-06-06 | 2009-12-10 | Asuragen, Inc. | Novel compositions for the in vivo delivery of rnai agents |
WO2010113177A2 (en) | 2009-03-31 | 2010-10-07 | Reliance Life Sciences Pvt. Ltd. | Oral insulin delivery systems for controlling diabetes |
KR101823699B1 (ko) | 2009-09-28 | 2018-01-30 | 인타르시아 세라퓨틱스 인코포레이티드 | 실질 항정상태 약물 전달의 신속 확립 및/또는 종결 |
EP2380920A1 (en) | 2010-04-22 | 2011-10-26 | QGel SA | Hydrogel precursor formulation and production process thereof |
CN104001159B (zh) | 2010-07-14 | 2016-08-24 | 中国医学科学院药物研究所 | 一种胰岛素的脂质复合物及其制备方法和制剂 |
US10695432B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
US11224659B2 (en) | 2010-10-29 | 2022-01-18 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
US9308213B2 (en) | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
US11202831B2 (en) | 2010-10-29 | 2021-12-21 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
US9744132B2 (en) | 2010-10-29 | 2017-08-29 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
US10695431B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
US9504664B2 (en) | 2010-10-29 | 2016-11-29 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US8895536B2 (en) | 2010-10-29 | 2014-11-25 | Infirst Healthcare Ltd. | Compositions and methods for treating chronic inflammation and inflammatory diseases |
US9271950B2 (en) | 2010-10-29 | 2016-03-01 | Infirst Healthcare Limited | Compositions for treating chronic inflammation and inflammatory diseases |
US11730709B2 (en) | 2010-10-29 | 2023-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
GB201107630D0 (en) * | 2011-05-06 | 2011-06-22 | Proxima Concepts Ltd | Microemulsions |
GB201107629D0 (en) * | 2011-05-06 | 2011-06-22 | Proxima Concepts Ltd | Hydrophobic preparations |
US10154964B2 (en) | 2011-09-07 | 2018-12-18 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
WO2013180253A1 (ja) | 2012-05-31 | 2013-12-05 | テルモ株式会社 | pH感受性担体およびその製造方法、並びに該担体を含むpH感受性医薬、pH感受性医薬組成物およびこれを用いた培養方法 |
SG11201505245XA (en) * | 2013-01-14 | 2015-08-28 | Infirst Healthcare Ltd | Compositions and methods for treating severe pain |
KR102252574B1 (ko) * | 2013-01-14 | 2021-05-17 | 인퍼스트 헬스케어 리미티드 | 고용체 조성물들 및 만성염증에서의 이의 용도 |
AU2014211715B2 (en) * | 2013-02-04 | 2016-08-25 | Infirst Healthcare Limited | Compositions and methods for treating chronic inflammation and inflammatory diseases |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
MX2017015504A (es) | 2015-06-03 | 2018-05-15 | Intarcia Therapeutics Inc | Sistemas de colocacion y remoción de implante. |
AU2017268161B2 (en) | 2016-05-16 | 2020-03-12 | Intarcia Therapeutics, Inc. | Glucagon-receptor selective polypeptides and methods of use thereof |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
AU2018206539A1 (en) | 2017-01-03 | 2019-07-18 | Intarcia Therapeutics, Inc. | Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53107408A (en) * | 1977-02-28 | 1978-09-19 | Yamanouchi Pharmaceut Co Ltd | Micellar preparation for rectal infusion |
ATE2688T1 (de) | 1979-06-11 | 1986-03-15 | Gebrueder Sulzer Aktiengesellschaft | Dreherfaden-liefereinrichtung fuer eine webmaschine. |
JP2556865B2 (ja) * | 1986-09-19 | 1996-11-27 | 山之内製薬株式会社 | ネオカルチノスタチン誘導体の非注射投与用組成物 |
ES2093269T3 (es) * | 1991-07-26 | 1996-12-16 | Smithkline Beecham Corp | Microemulsiones del tipo agua en aceite. |
EP0671929A4 (en) * | 1992-10-16 | 1996-09-25 | Smithkline Beecham Corp | COMPOSITIONS. |
WO1994008605A1 (en) * | 1992-10-16 | 1994-04-28 | Smithkline Beecham Corporation | Therapeutic microemulsions |
GB9224502D0 (en) * | 1992-11-23 | 1993-01-13 | New Roger R C | Method of preparing a lipid-containing formulation |
JPH08507078A (ja) * | 1993-02-17 | 1996-07-30 | スミスクライン・ビーチャム・コーポレイション | 治療用ペプチド含有のミクロエマルジョン |
GB9323588D0 (en) * | 1993-11-16 | 1994-01-05 | Cortecs Ltd | Hydrophobic preparation |
GB9422990D0 (en) | 1994-11-15 | 1995-01-04 | Cortecs Ltd | Immunogenic compositions |
GB9424902D0 (en) * | 1994-12-09 | 1995-02-08 | Cortecs Ltd | Solubilisation Aids |
GB9424901D0 (en) * | 1994-12-09 | 1995-02-08 | Cortecs Ltd | Sequestration Agents |
GB9605709D0 (en) | 1996-03-19 | 1996-05-22 | Cortecs Ltd | Method |
-
1996
- 1996-07-02 GB GBGB9613858.1A patent/GB9613858D0/en active Pending
-
1997
- 1997-07-01 ZA ZA975856A patent/ZA975856B/xx unknown
- 1997-07-02 CA CA002259233A patent/CA2259233A1/en not_active Abandoned
- 1997-07-02 BR BR9710179A patent/BR9710179A/pt not_active Application Discontinuation
- 1997-07-02 JP JP10503931A patent/JP2000515130A/ja active Pending
- 1997-07-02 WO PCT/GB1997/001775 patent/WO1998000169A1/en not_active Application Discontinuation
- 1997-07-02 NZ NZ333115A patent/NZ333115A/en unknown
- 1997-07-02 EP EP97929411A patent/EP0910411A1/en not_active Withdrawn
- 1997-07-02 ID IDP972303A patent/ID18568A/id unknown
- 1997-07-02 KR KR1019980710781A patent/KR20000022353A/ko not_active Application Discontinuation
- 1997-07-02 AU AU33526/97A patent/AU709013B2/en not_active Ceased
-
1998
- 1998-12-22 US US09/218,289 patent/US6258377B1/en not_active Expired - Fee Related
- 1998-12-30 NO NO986211A patent/NO986211L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0910411A1 (en) | 1999-04-28 |
JP2000515130A (ja) | 2000-11-14 |
WO1998000169A1 (en) | 1998-01-08 |
GB9613858D0 (en) | 1996-09-04 |
NZ333115A (en) | 2000-06-23 |
ZA975856B (en) | 1999-01-04 |
CA2259233A1 (en) | 1998-01-08 |
NO986211L (no) | 1999-03-02 |
NO986211D0 (no) | 1998-12-30 |
KR20000022353A (ko) | 2000-04-25 |
AU3352697A (en) | 1998-01-21 |
AU709013B2 (en) | 1999-08-19 |
US6258377B1 (en) | 2001-07-10 |
ID18568A (id) | 1998-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9710179A (pt) | Preparação hidrofóbica preparação em emulação farmacéutica e uso de uma preparação hidrofóbica | |
BR9608824A (pt) | Macrômeros de polissiloxano-poliol preparação e uso dos mesmos | |
PT1270565E (pt) | Furano-2-sulfonamida 4-substituida e sua utilizacao na preparacao de derivados de sulfonilureia | |
DE69618587T2 (de) | Chinazoline und pharmazeutische zusammensetzungen | |
DE69622735D1 (de) | Lyophilisierte stabile pharmazeutische formulierung | |
AU3890297A (en) | Herbal formulation and therapeutic uses therefor | |
BR9802130A (pt) | Compostos triaromáticos composição farmacêutica composição cosmética e uso de uma composição cosmética | |
DE59704397D1 (de) | Kosmetische und/oder pharmazeutische zubereitungen | |
PT1006110E (pt) | Derivados de acil-piperazinil-pirimidinas sua preparacao e aplicacao como medicamentos | |
PT832104E (pt) | Derivados de dolastatina sua preparacao e utilizacao | |
BR9306247A (pt) | Composiçoes alimentícias derivadas de vitamina d e métodos de uso | |
ZA9810543B (en) | Substituted imidazolidine derivatives their preparation their use and pharmaceutical preparations comprising them | |
BR9708902A (pt) | Derivados de benzofurila e seu uso | |
BR9608376A (pt) | Utilização em cosméticos de uma composição sólida expandida composição de uso cosmético ou dermatológico processo de preparação de uma composição e utilização de composição | |
BR9602915A (pt) | Medicamentos uso e formulação farmacêutica | |
DE59607535D1 (de) | Kosmetische und/oder pharmazeutische zubereitungen | |
BR9502691A (pt) | Uso de ácido hialurônico e dispositivo protético | |
BR9707812A (pt) | Composto composto farmacêutica e uso do composto | |
DE59805545D1 (de) | Wässrige kosmetische zubereitungen in stiftform | |
IL126247A0 (en) | Novel imidazolidine derivatives their preparation their use and pharmaceutical preparations comprising them | |
BR9708790A (pt) | Composto uso de um composto e formulação farmacêutica | |
PT1025100E (pt) | Derivados de tetra-hidropiridopirimidona substituidos na posicao 3 sua preparacao e sua utilizacao | |
BR9606856A (pt) | Uso dermatológico de derívados de vitamina d | |
BR9800753B1 (pt) | composição cosmética e/ou dermatológica e uso de uma composição. | |
DE59505714D1 (de) | Kosmetische und/oder pharmazeutische zubereitungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |